References

Data on file, 2024 (Romania), Stratpharma AG

Data on file, 2025 (Romania), Stratpharma AG

Bensadoun, R., et al. (2013). Cancer management and research, 5, pp. 401-408.

Segaert, S., Van Cutsem, E. (2005). Annals of oncology, 16(9), pp. 1425-1433.

National Cancer Institute (2019). Skin and Nail Changes. Available at: https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes. Accessed: June 3, 2019.

Lacouture, M., et al. (2011). Supportive care in cancer, 19(8), pp. 1079-1095.

American Academy of Dermatology. Rash in 101 adults: When to seek medical treatment. Available at: https://www.aad.org/public/everyday-care/itchy-skin/rash/rash-101. Accessed: July 9, 2019.

Przybylski, D. R., et al. (2018). J of Drugs in Dermatology, 17(2), 146-149.

Hengge, U. R., et al. (2006). J of the American Academy of Dermatology, 54(1), pp. 1–18.

Beech, J., et al. (2018). Future Oncology, 14(24), pp. 2531-2541.

Chularojanamontri, L., et al. (2019). Asian Pacific J Allergy Immunology, 37(1), pp. 12-18.

Shergold, J., Poster presented at Australian and New Zealand Children’s Hematology/ Oncology Group (ANZCHOG) Annual Scientific Meeting, Jun 15-17, 2017, Adelaide, Australia.

Cubiró Raventós, X., et al. (2018). SKINmed. 17(5), pp. 298–304.

Boucher, J., Olson, L., Piperdi, B. (2011). Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors. Clinical Journal of Oncology Nursing, 15(5), 501–508. DOI: 10.1188/11.CJON.501-508.

Carlos, Giuliana & Uribe, Pablo & Fernandez-Peñas, Pablo. (2013). Rational use of topical corticosteroids. Australian Prescriber. 36. 158–161. DOI: 10.18773/austprescr.2013.063.

Steele, CE. et al. (2019). Current opinion in pediatrics, 31(4), pp. 515–522.

Smriti KR. et al. (2014). Autoimmunity Reviews, 13(4-5), pp. 490-495.

Boehncke, WH., Schön, MP. (2015). Lancet, 386(9997), pp. 983–994.